BioNTech SE (30 March 2021), FY 2020 results (ภาษาอังกฤษ), Biontech SE, สืบค้นเมื่อ 2 July 2021
"SEC Filing | BioNTech". investors.biontech.de. สืบค้นเมื่อ 28 December 2020.
Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature (ภาษาอังกฤษ), 534 (7607), pp. 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, สืบค้นเมื่อ 11 November 2020
Spalding, Rebecca; Franklin, Joshua (9 October 2019). "Germany's BioNTech raises $150 million in smaller-than-planned U.S. IPO amid market volatility". Reuters. สืบค้นเมื่อ 7 December 2020.
Vaccines and Related Biological Products Advisory Committee Meeting December 10, 2020: FDA Briefing Document – Pfizer-BioNTech COVID-19 Vaccine (รายงาน). https://www.fda.gov/media/144245/download. เรียกข้อมูลเมื่อ 2021-07-04.
สิงหาคม 04, 2021
ไบออนเทค, biontech, เป, นบร, ทเทคโนโลย, วภาพของประเทศเยอรมน, สำน, กงานใหญ, งอย, นครไมนทซ, ฐไรน, นท, ลทซ, เป, นผ, ผล, ตช, วเภส, ชภ, ณฑ, ชน, ดภ, มก, นบำบ, ดจาก, mrna, สำหร, บการร, กษาโรคมะเร, งและโรคต, ดเช, อต, างๆheadquarters, mainzประเภทบร, ทจำก, ดการซ, อขายna. ibxxnethkh BioNTech epnbristhethkhonolyichiwphaphkhxngpraethseyxrmni sanknganihytngxyuthinkhrimnths rthirnlnth flths ibxxnethkhepnphuphlitchiwephschphnthchnidphumikhumknbabdcak mRNA sahrbkarrksaorkhmaerngaelaorkhtidechuxtangibxxnethkhHeadquarters in MainzpraephthbristhcakdkarsuxkhayNASDAQ BNTXISINUS09075V1026xutsahkrrmethkhonolyichiwphaphkxtng2008 13 pithiaelw 2008 sanknganihyAn der Goldgrube 12 Mainz Germanycanwnthitng8 2020 phunthithiihbrikarthwolkphlitphnthBNT162b2brikarphumikhumknbabdrayid108 589 000 yuor ph s 2562 kair 181 518 000 yuor ph s 2562 rayidsuththi 179 172 000 yuor ph s 2562 sinthrphy797 647 000 yuor ph s 2562 phnkngan1 323 2019 ewbistbiontech wbr deechingxrrth xangxingBiontech FY 2020 report 1 ibxxnethkhkxtnginkh s 2008 cakkarrwmklumkhxngnkwicyhlaykhndwyenginthuntngtn 150 lanyuor 2 odymungennphthnachiwephschphnthuchnidphumikhumknbabdaelaethkhonolyisahrbrksaorkhmaerngepnhlk ibxxnethkhephyaephrphlwicykhxngklik mRNA odytlxdrahwangkh s 2014 thung 2018 3 inkh s 2019 bristhtngsanknganihmthinkhrekhmbridc shrthxemrika aelaidrbenginlngthuncakmulnithiekts canwn 55 landxllarshrth aelaradmthunphankarcahnayhunkhrngaerk IPO caktladhlkthrphyaensaedkidengincanwn 150 landxllarshrthinpiediywkn 4 inkh s 2020 ibxxnethkhrwmthunkbbristhifesxrinkarphthnawkhsin BNT162b2 chnid RNA sungmiprasiththiphaphkarpxngknorkhokhwid 19 thung 95 hlngidrbwkhsinekhmthisxnghangcakekhmaerkxyangnxyecdwn 5 xangxing aekikh BioNTech SE 30 March 2021 FY 2020 results phasaxngkvs Biontech SE subkhnemux 2 July 2021 SEC Filing BioNTech investors biontech de subkhnemux 28 December 2020 Kranz Lena M Diken Mustafa Haas Heinrich Kreiter Sebastian Loquai Carmen 16 June 2016 Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy Nature phasaxngkvs 534 7607 pp 396 401 Bibcode 2016Natur 534 396K doi 10 1038 nature18300 ISSN 1476 4687 PMID 27281205 subkhnemux 11 November 2020 Spalding Rebecca Franklin Joshua 9 October 2019 Germany s BioNTech raises 150 million in smaller than planned U S IPO amid market volatility Reuters subkhnemux 7 December 2020 Vaccines and Related Biological Products Advisory Committee Meeting December 10 2020 FDA Briefing Document Pfizer BioNTech COVID 19 Vaccine rayngan https www fda gov media 144245 download eriykkhxmulemux 2021 07 04 ekhathungcak https th wikipedia org w index php title ibxxnethkh amp oldid 9526245, wikipedia, วิกิ หนังสือ, หนังสือ, ห้องสมุด,
